The European Medicines Agency has issued a press release recommending that Gilenya (fingolimod) not be used during pregnancy or by women of child-baring age who are not using effective contraception.
New €3.9 million NUI Galway-led European consortium to train researchers in developing new treatments for Multiple Sclerosis
Research shows online supports vital as majority of carers feel isolated in their role
NEW Research shows that 44% of Irish people have poor understanding of the symptoms and nature of Multiple Sclerosis (MS)[1]
© 2010 - 2022 Multiple Sclerosis Society of Ireland